Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Wertheim cung cấp cho các bạn kiến thức về ngành y đề tài: Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses. | AIDS Research and Therapy BioMed Central Research Open Access Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses Patricia Cornejo-Juarez Patricia Volkow-Fernándezt1 Kenia Escobedo- Lopez2 Diana Vilar-Compte1 Guillermo Ruiz-Palacios2 and Luis Enrique Soto-Ramírezt2 Address 1Infectious Diseases Institute Nacional de Cancerología Mexico City México. Av. San Fernando No. 22 Col. Sección XVI Tlalpan 14000 México Mexico and 2Infectious Diseases Institute Nacional de Ciencias Médicas y de la Nutrición. Salvador Zubiran Mexico City Mexico Email Patricia Cornejo-Juarez - patcornejo@ Patricia Volkow-Fernandez - volkow@ Kenia Escobedo-Lopez - kemesk@ Diana Vilar-Compte - diana-vilar@ Guillermo Ruiz-Palacios - gmrps@ Luis Enrique Soto-Ramirez - lsoto@ Corresponding author tEqual contributors Published 06 April 2006 AIDS Research and Therapy2006 3 9 doi 1742-6405-3-9 Received 18 October 2005 Accepted 06 April 2006 This article is available from http content 3 1 9 2006Cornejo-Juárez et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Co-infection with hepatitis B virus HBV and human immunodeficiency virus HIV is not infrequent as both share same route of exposure. The risk of developing chronic hepatitis B virus is 6 in general population but can reach 10-20 in HBV HIV co-infected patients. When compared to general population the response rate to HBV vaccine in HIV-infected patients is diminished so previous studies have tried to improve this response using variety of schedules doses and co-administration of immunomodulators. The .
